Kaji Ryuji | Department Of Clinical Neuroscience Institute Of Health Biosciences The University Of Tokushima Graduate School
スポンサーリンク
概要
- KAJI Ryujiの詳細を見る
- 同名の論文著者
- Department Of Clinical Neuroscience Institute Of Health Biosciences The University Of Tokushima Graduate Schoolの論文著者
関連著者
-
Kaji Ryuji
Department Of Clinical Neuroscience Institute Of Health Biosciences The University Of Tokushima Graduate School
-
Kaji Ryuji
Department Of Clinical Neuroscience Tokushima University Hospital
-
Izumi Yuishin
Department Of Clinical Neuroscience Institute Of Health Biosciences The University Of Tokushima Graduate School
-
Nakagawa Masanori
Department of Neurology and Gerontology, Research Institute for Neurological Diseases and Geriatrics
-
Nagahiro Shinji
Department Of Neurosurgery Institute Of Health Biosciences The University Of Tokushima Graduate Scho
-
TAKASHIMA Hiroshi
Department of Neurology and Geriatrics, Graduate School of Medical and Dental Sciences, Kagoshima Un
-
MAEDA Kouji
Department of Mechanical and System Engineering, University of Hyogo
-
NODERA Hiroyuki
Department of Neurology, The University of Tokushima
-
Nakagawa Masanori
Department Of Neurology And Gerontology Kyoto Prefectural University Graduate School Of Medicine
-
Kusunoki Susumu
Department Of Neurology Graduate School Of Medicine University Of Tokyo
著作論文
- Anti-neuronal Antibodies in Acute Pandysautonomia
- Refinement of a locus for autosomal dominant hereditary motor and sensory neuropathy with proximal dominancy (HMSN-P) and genetic heterogeneity
- Amyotrophic lateral sclerosis with IgM antibody against gangliosides GM2 and GD2
- Prevalence of inositol 1, 4, 5-triphosphate receptor type 1 gene deletion, the mutation for spinocerebellar ataxia type 15, in Japan screened by gene dosage
- Basal Ganglia Hyperintensity on T1-weighted Imaging of a Patient with Central Nervous System Metastasis Producing Carcinoembryonic Antigens
- Safety and Efficacy of Intravenous Ultra-high Dose Methylcobalamin Treatment for Peripheral Neuropathy: A Phase I/II Open Label Clinical Trial